ApprovalTrail

Drug · DIN 02239031

RELAXOPHEN CAPLETS

Authorized, but not sold for a year or more

Authorized, but the company reports it has not been sold in Canada for at least 12 months.

Status Dormant since July 25, 2017; first marketed December 18, 2000.
Drug Identification Number (DIN)
02239031
Company (DIN owner)
Tanta Pharmaceuticals IncWhitby, Ontario, Canada
Schedule
Non-prescription drugs
Dosage form
Tablet
Route
Oral
Therapeutic class (ATC)
Methocarbamol, combinations excl psycholeptics M03BA53
Class
Human
Record last updated
March 22, 2025

Active ingredients

As listed in the Drug Product Database.

IngredientStrengthPer
METHOCARBAMOL400 MG
ACETAMINOPHEN325 MG